Sartorius Aktiengesellschaft (0NIQ.L)
EUR 192.8
(5.7%)
EUR 192.8
(5.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.27 Billion EUR | 107.7% |
| 2022 | 2.54 Billion EUR | 22.44% |
| 2021 | 2.07 Billion EUR | -0.57% |
| 2020 | 2.08 Billion EUR | 95.36% |
| 2019 | 1.06 Billion EUR | 6.35% |
| 2018 | 1 Billion EUR | 5.2% |
| 2017 | 954.97 Million EUR | 74.28% |
| 2016 | 547.93 Million EUR | 38.98% |
| 2015 | 394.24 Million EUR | 1.15% |
| 2014 | 389.77 Million EUR | -3.08% |
| 2013 | 402.14 Million EUR | 0.0% |
| 2012 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 4.39 Billion EUR | -4.33% |
| 2024 Q2 | 4.59 Billion EUR | -11.71% |
| 2024 Q1 | 5.19 Billion EUR | -2.1% |
| 2023 Q4 | 5.31 Billion EUR | -0.98% |
| 2023 FY | 5.31 Billion EUR | 109.01% |
| 2023 Q1 | 2.6 Billion EUR | 2.49% |
| 2023 Q2 | 2.77 Billion EUR | 6.48% |
| 2023 Q3 | 5.36 Billion EUR | 93.4% |
| 2022 Q3 | 2.57 Billion EUR | 22.03% |
| 2022 Q1 | 2.05 Billion EUR | -0.86% |
| 2022 FY | 2.54 Billion EUR | 22.44% |
| 2022 Q2 | 2.11 Billion EUR | 2.63% |
| 2022 Q4 | 2.54 Billion EUR | -1.4% |
| 2021 Q4 | 2.07 Billion EUR | -2.46% |
| 2021 Q2 | 2.12 Billion EUR | 0.0% |
| 2021 FY | 2.07 Billion EUR | -0.57% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 2.12 Billion EUR | 0.27% |
| 2020 Q4 | 2.06 Billion EUR | 0.03% |
| 2020 Q3 | 2.06 Billion EUR | 12.27% |
| 2020 FY | 2.08 Billion EUR | 95.36% |
| 2020 Q1 | 1.05 Billion EUR | 0.93% |
| 2020 Q2 | 1.84 Billion EUR | 73.74% |
| 2019 Q3 | 1.06 Billion EUR | -0.95% |
| 2019 FY | 1.06 Billion EUR | 6.35% |
| 2019 Q4 | 1.04 Billion EUR | -1.26% |
| 2019 Q2 | 1.07 Billion EUR | 6.86% |
| 2019 Q1 | 1 Billion EUR | 0.26% |
| 2018 Q2 | 1 Billion EUR | 3.82% |
| 2018 Q3 | 1.02 Billion EUR | 2.12% |
| 2018 Q1 | 966.79 Million EUR | 1.56% |
| 2018 FY | 1 Billion EUR | 5.2% |
| 2018 Q4 | 1 Billion EUR | -2.25% |
| 2017 Q2 | 989.4 Million EUR | 5.72% |
| 2017 FY | 954.97 Million EUR | 74.28% |
| 2017 Q4 | 951.97 Million EUR | -2.17% |
| 2017 Q3 | 973.1 Million EUR | -1.65% |
| 2017 Q1 | 935.9 Million EUR | 71.75% |
| 2016 Q1 | 410.1 Million EUR | 4.02% |
| 2016 Q4 | 544.91 Million EUR | -2.33% |
| 2016 Q3 | 557.9 Million EUR | 0.09% |
| 2016 Q2 | 557.4 Million EUR | 35.92% |
| 2016 FY | 547.93 Million EUR | 38.98% |
| 2015 Q1 | 339.29 Million EUR | -12.95% |
| 2015 FY | 394.24 Million EUR | 1.15% |
| 2015 Q4 | 394.24 Million EUR | 7.78% |
| 2015 Q3 | 365.8 Million EUR | 4.28% |
| 2015 Q2 | 350.8 Million EUR | 3.39% |
| 2014 Q2 | 411.2 Million EUR | 5.27% |
| 2014 Q1 | 390.6 Million EUR | -2.87% |
| 2014 FY | 389.77 Million EUR | -3.08% |
| 2014 Q4 | 389.77 Million EUR | -5.28% |
| 2014 Q3 | 411.5 Million EUR | 0.07% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q3 | 366.1 Million EUR | -3.4% |
| 2013 Q4 | 402.14 Million EUR | 9.85% |
| 2013 Q2 | 379 Million EUR | 0.0% |
| 2013 FY | 402.14 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cegedim SA | 285.1 Million EUR | -1751.302% |
| Guerbet SA | 364.58 Million EUR | -1347.689% |
| Nexus AG | 20.24 Million EUR | -25971.129% |
| Bastide Le Confort Médical SA | 356.96 Million EUR | -1378.592% |
| Revenio Group Oyj | 18.7 Million EUR | -28125.134% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | -1019.705% |
| LNA Santé SA | 887.67 Million EUR | -494.6% |
| Siemens Healthineers AG | 633 Million EUR | -733.823% |
| Medios AG | 17.14 Million EUR | -30679.683% |
| Equasens Société anonyme | 69.27 Million EUR | -7519.274% |
| Stratec SE | 141.37 Million EUR | -3633.51% |